Professor Fournier is an exercise biochemist/physiologist who received his PhD from Laval University, Canada, before joining the School of Sport Science, Exercise and Health at the University of Western Australia. Professor Fournier specialises in the field of bioenergetics in exercise, health and disease. This discipline is concerned with not only the regulation of energy utilisation, intake and storage but also with the mechanisms whereby these processes are affected by exercise, nutrition and metabolic disorders such as obesity and diabetes. Exercise as a therapeutic tool for the prevention of hypoglycaemia in Type 1 Diabetes is one of his focus areas. The success of the research programs initiated by Professor Fournier is best illustrated by the many national competitive grants he has been awarded since the start of his career, his published work in high impact journals, and the many postgraduate students he has supervised. Read more about Professor Fournier here.
Professor Donna Cross is a Winthrop Professor with the Faculty of Medicine, Dentistry and Health Sciences at the University of Western Australia and the Telethon Kids Institute.
Professor Cross has been awarded more than $13 million in national and State competitive grants, including eight NHMRC grants, six ARC grants and 35 WA Health Promotion Foundation research grants. This funding has supported 52 applied intervention research programs to address child and adolescent health issues related to mental health, injury control, drug use control and healthy lifestyles.
Professor Cross has an international reputation for developing community-based interventions to reduce bullying and aggression among young people. She is currently the lead investigator on seven longitudinal research projects aiming to prevent bullying, cyberbullying and associated mental health harms among Australian children and adolescents. Her strong focus on translational strategies has culminated in the dissemination of school curriculum and bullying prevention resources to more than 3,000 Australian schools.
Professor Cross's research has contributed to sustainable policy and practice change, including sun safety policies (such as 'no hat, no play') and national and State policy for bullying prevention and management.
Since 1999, Professor Cross and her colleagues have completed 30 large empirical trials, each involving more than 2,000 school-age students, investigating ways to improve their health. These included two large studies involving Aboriginal and Torres Strait Islander students. More than 3,000 Australian schools are implementing the evidenced-based program called Friendly Schools Plus, developed by Professor Cross and her team of researchers as a result of six randomised control trials.
In 2012, she received the award for WA Australian of the Year for her services to children's health.
Associate Professor Geelhoed is currently a Professor in Health Economics and Head of School within the School of Population Health at The University of Western Australia and has worked as a health economist in education, research and policy development over the past 22 years. Professor Geelhoed is actively involved in both teaching and research at UWA and is an executive member of CAPHIA (Council of Academic Public Health Institutions Australia), which is the national body representing public health education programs across Australia. Currently funded research projects focus on the economic implications of interventions and reflect an interest in equity for disadvantaged populations, for example the translation of primary healthcare policy into service delivery in rural and remote areas in WA, the management of coronary heart disease in Indigenous populations in Western Australia and the impact of treatment-focused genetic testing in rare diseases.
Schreuders, L.W., Bremner, A.P., Geelhoed, E., Finn, J. 2015, 'The relationship between nurse staffing and inpatient complications', JOURNAL OF ADVANCED NURSING, 71, pp. 800-812.
Teng, T.H.K., Katzenellenbogen, J.M., Hung, J., Knuiman, M., Sanfilippo, F.M., Geelhoed, E., Bessarab, D., Hobbs, M., Thompson, S.C. 2015, 'A cohort study: temporal trends in prevalence of antecedents, comorbidities and mortality in Aboriginal and non-Aboriginal Australians with first heart failure hospitalization, 2000-2009', International Journal for Equity in Health, 14, 1,
Lim, D., Geelhoed, E. 2015, 'General practice coordinated chronic disease management to reduce avoidable hospital admission', Australasian Medical Journal, 8, 7, pp. 249-250.
Teng, T.K., Katzenellenbogen, J.M., Thompson, S.C., Sanfilippo, F.M., Knuiman, M.W., Geelhoed, E.A., Hobbs, M.S.T., Bessarab, D.C., Hung, J. 2014, 'Incidence of first heart failure hospitalisation and mortality in Aboriginal and non-Aboriginal patients in Western Australia, 2000-2009', International Journal of Cardiology, 173, 1, pp. 110-117.
Schreuders, L.W., Bremner, A.P., Geelhoed, E.A., Finn, J.C. 2014, 'Using linked hospitalisation data to detect nursing sensitive outcomes: A retrospective cohort study', International Journal of Nursing Studies, 51, 3, pp. 470-478.
Professor of Nursing and Pediatrics, Yale University, USA
Margaret Grey, DrPH, RN, FAAN, was the ninth dean of the Yale School of Nursing and is the School's Annie Goodrich Professor of Nursing. She has been at Yale since 1993. She directs the Community Engagement Core for the Yale Center for Clinical Investigation. She holds a bachelor's degree from the University of Pittsburgh, an MSN in paediatric nursing from Yale University, and a Doctorate in Public Health and social psychology from Columbia University.
A paediatric nurse practitioner, Dr Grey's research has focused on improving self-management in youth with diabetes mellitus, and the study of psychoeducational interventions that improve both metabolic control of diabetes and the quality of life in young people and their parents. Preventing type 2 diabetes in high risk youth and lifestyle management of youth with type 2 diabetes are also an interest. She has been principal investigator for grants totaling more than $45 million.
Dr Grey is the author of more than 380 journal articles, chapters and abstracts and has received numerous regional and national honours for her research. She was elected to the Institute of Medicine in 2005. She was elected to the Sigma Theta Tau International Nurse Researcher Hall of Fame. She is the recipient of the Richard R. Rubin Award for Outstanding Contributions to Behavioral Medicine from the American Diabetes Association, the Pathfinder Award from the Friends of the National Institute of Nursing Research, Outstanding Nurse Scientist Award from the Council for the Advancement of Nursing Science, the Excellence in Nursing Research Award from the Association of Faculties of Pediatric Nurse Practitioner Programs, the Achievement in Research Award from the National Organization of Nurse Practitioner Faculties, among others. the Outstanding Nurse Researcher Award from the Eastern Nursing Research Society, and the Virginia Henderson Award for Outstanding Contributions to Nursing Research from the Connecticut Nurses' Association, among other awards. Dr. Grey is also a Distinguished Fellow of the National Association of Pediatric Nurse Associates and Nurse Practitioners, and a Fellow in the Society of Behavioral Medicine. She was elected to the American Academy of Nursing in 1990.
Research Interests: Diabetes in childhood, prevention of type 2 diabetes in high risk youth.
Chief, Pediatric Endocrinology, Yale University, USA
Professor Tamborlane, MD, is a graduate of Georgetown University School of Medicine, where he completed his residency in paediatrics before going to Yale as a postdoctoral fellow in paediatric endocrinology. His scientific accomplishments over the past 40 years have established his international reputation as one of the most highly regarded clinical scientists in childhood diabetes and related disorders. He has published more than 750 original articles, chapters and reviews in the area of diabetes.
Major accomplishments have included pioneering studies in the development of insulin pump therapy, direction of the Yale Center in the DCCT/EDIC study, and investigations of diabetes-induced defects in counterregulatory hormone responses to hypoglycemia. Current research efforts are directed at applying recent advances in insulin pump and glucose sensor technology towards the development of an artificial pancreas.
He is the recipient of many awards and honours and is frequently listed in publications of distinction, including American Men and Women of Science, The Best Doctors in America, America's Top Doctors and America's Top Pediatricians. In 2006 and 2011, he was awarded the Mary Tyler Moore and S. Robert Levine Award for Excellence in Clinical Research in Type 1 Diabetes by the Juvenile Diabetes Research Foundation. He also received the 2009 Diabetes Technology Society's Diabetes Technology Leadership Award, the 2010 American Diabetes Association Outstanding Physician Clinician Award and the National Award for Career Achievement and Contributions to Clinical, the Translational Science by ACRT/SCTS/AFMR and the 2014 International Society for Pediatric and Adolescent Diabetes Prize for Achievement. He is frequently listed in publications such as The Best Doctors in America, and America's Top Doctors. He has served on the FDA's Endocrine Advisory Board and on the National Board of Directors of the American Diabetes Association and was the first Steering Committee Chair of the Diabetes Research in Children Network, is Chair of the Pediatric Diabetes Consortium and former Vice Chair (for Pediatrics) of the T1D Exchange Clinic Registry.
He leads a multidisciplinary team of physicians, diabetes nurse educators, dieticians and social workers that care for more than 1000 children, adolescents and young adults with diabetes.
Associate Professor Stuart Alan Weinzimer
Associate Professor of Pediatrics (Endocrinology) and Associate Clinical Professor of Nursing, Yale University, USA
Associate Professor Weinzimer earned his bachelor's degree in molecular biochemistry and biochemistry at Yale University and medical degree at the Albert Einstein College of Medicine. He completed his residency training in pediatrics and fellowship training in paediatric endocrinology at the Children's Hospital of Philadelphia (CHOP), and joined the faculty in the Department of Pediatrics at the University of Pennsylvania. In 2002 he returned to Yale to focus his research on the continuous glucose sensors and insulin pumps towards the development of an artificial pancreas.
He is the principal investigator of several NIH and JDRF- funded artificial pancreas projects. In 2006 he earned Yale's Mae Gailani Award for Outstanding Clinical Care and Research, and in 2009 he received the Dream Award from the Greater New Haven Chapter of the JDRF. In 2011 he was awarded, along with other principal investigators in the JDRF Continuous Glucose Monitoring Study Group, the Mary Tyler Moore and S. Robert Levine, MD Excellence in Clinical Research Award.